Menveo vaccine VL 5S
Ended Awarded Last action
- Contract number
- SPE2DR26FAURP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $159,434
Award facts
- Contract value 100% obligated
- $159,434.31 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a firm fixed-price delivery order valued at $159,434.31 by the Defense Logistics Agency (DLA) on February 4, 2026, for the supply of Menveo vaccine (5-vial configuration). This is a non-set-aside, competitively awarded contract with performance to be completed at the company's facility in Conshohocken, Pennsylvania. The delivery order represents a task order executed under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
The Menveo vaccine delivery supports critical immunization requirements across the Department of Defense healthcare system. Amerisourcebergen's position as a prime pharmaceutical vendor to DLA underscores its essential role in the federal medical supply chain, serving military treatment facilities, veterans' healthcare programs, and other government medical institutions. The company's extensive experience delivering diverse pharmaceutical commodities—from specialty medications to vaccines and medical devices—demonstrates its capability to meet federal procurement standards through open competition and maintain consistent supply of vaccines and other critical medical products required by military and defense-related healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FAURP?
SPE2DR26FAURP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FAURP worth?
The government has obligated $159,434 on SPE2DR26FAURP.
Is contract SPE2DR26FAURP an order under another contract?
Yes. SPE2DR26FAURP is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FAURP competed?
The extent of competition for SPE2DR26FAURP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award